<div class="container">Avalon Biomedical (Management) Limited is a pioneering life sciences company driving biomedical innovation through cutting-edge research, technology integration, and cross-disciplinary collaboration. As part of our strategic expansion, we are advancing AI-driven healthcare solutions in drug discovery, medical imaging, equipment maintenance, and traditional Chinese medicine—prioritizing data security, regulatory compliance, and assistive applications for healthcare professionals. Our AI solutions enhance clinical decision-making, optimize hospital operations, and transform medical education. Through strong partnerships with academia, industry, and healthcare institutions, we are accelerating intelligent, precision-driven healthcare development while shaping a smarter, more connected biomedical ecosystem.<br /><br /></div><div style="padding-bottom: 100px;"> </div>

Avalon Biomedical (Management) Limited

<div class="container">Emerging Viral Diagnostics (Hong Kong) Limited (EVDL) is a Hong Kong-based MedTech company composed of a team of experienced interdisciplinary experts. By integrating academic, industrial, and research expertise, the company successfully transformed the "Fully Automated Multiplex Diagnostic System" from an unmet medical need into an innovative and practical diagnostic solution. In 2024, this system was recommended by the World Health Organization as an innovative health technology suitable for low-resource settings and was softly launched to the market. EVDL is committed to becoming a global leader in the diagnostic industry, continuously pushing Diagnosis beyond Boundaries!</div><div style="padding-bottom: 100px;"> </div>

Emerging Viral Diagnostics (Hong Kong) Limited

<div class="container">Eieling Technology is dedicated to advancing liver health through the seamless integration of cutting-edge technology and clinical medicine. Our pipelines are committed to providing healthcare providers with accurate, efficient, and reliable diagnostic solutions for liver disease managements.<br><br>Focusing on the core needs of liver disease prevention, diagnosis, and treatment, Eieling offers a range of advanced products that address every stage of liver care. Our comprehensive, multi-dimensional diagnostic and data management systems provide clinicians with powerful tools for early detection, real-time assessment, and long-term disease management.
</div><div style="padding-bottom: 100px;"> </div>

Eieling Technology Limited

<div class="container">HIHUB.TECH@Health Innova HUB is a Leading Brazilian HUB Focused on Developing and promoting businesses among Healthcare Innovation Leaders.<br /><br />Our clients are among the most successful business Healthcare Leaders, in Brazil, located all over the country and abroad.<br /><br />We have 4 Pillars: Academy, Members, Challenges and Experiences and we promote exclusive events to promote networking and business relations among our attendees.<br /><br />We have already promoted 4 Healthcare Innovation Missions to Silicon Valley, One to Canada and One to China, in 2019.<br /><br />This year, 2025, we are returning to China with a Delegation, of 16 CEOs and Healthcare Innovation Leaders, looking for solutions to bring to Brazil.<br /><br />Website: <a style="color: #41aead;" href="https://hihub.tech" target="_blank" rel="noopener">https://hihub.tech</a></div><div style="padding-bottom: 100px;"> </div>

HIHUB.TECH@Health Innova HUB

Jiangsu ZhiziNano

<div class="container">Merck is a leading science and technology company with a rich history dating back to 1668. With approximately 63,000 employees worldwide, Merck operates in three main sectors: Healthcare, Life Science and Electronics. The company is dedicated to improving the quality of life through innovative solutions in pharmaceuticals, biotechnology and high-tech materials. Merck Healthcare aims to improve patient outcomes through advanced therapies in areas such as oncology, neurology and immunology. Emphasizing patient-centric approaches, Merck collaborates with healthcare professionals to ensure accessibility and effectiveness of the products, and is committed to making a positive impact on society.</div><div style="padding-bottom: 100px;"> </div>

Merck

<div class="container">Nano and Advanced Materials Institute (NAMI) is designated by the Innovation and Technology Commission of HKSAR Government as a Research and Development Center for nanotechnology and advanced materials. NAMI undertakes and provides support for market-driven research in nanotechnology and advanced materials, and strives for commercialization of the technologies to benefit the industry and society at large, as well as new industrialization to promote economic growth and sustainability of Hong Kong.<br /><br />As a Materials Expert, NAMI has a strong portfolio of innovative technologies to support and collaborate with industry, offering frontier-applied research on advanced materials and technology transfer for commercialization success.<br /><br />Website: <a style="color: #41aead;" href="https://www.nami.org.hk" target="_blank" rel="noopener">https://www.nami.org.hk</a></div><div style="padding-bottom: 100px;"> </div>

Nano and Advanced Materials Institute

<div class="container">From medical clinics to community pharmacies, Scribo revolutionizes operations of diverse primary healthcare practices and elevate patient experiences with our intelligent and data-driven SaaS solution. With expertise in drug utilization data management backed by our co-founding team of pharmacists, we also offer solutions for the pharmaceutical industry in digitizing operations of drug access programs they sponsor, fostering seamless collaborations with healthcare providers.</div><div style="padding-bottom: 100px;"> </div>

Scribo Limited

<div class="container">The Shenzhen Pingshan Biomedical Industry Accelerator Park is located within the National Bio-industry Base of Pingshan High-tech Zone. It covers an area of approximately 106,000 square meters and has a total construction area of about 691,200 square meters. The park consists of 14 buildings, including 115,300 square meters of research and development facilities, 283,100 square meters of production plants, and approximately 87,000 square meters of multi-functional supporting facilities such as apartments and commercial amenities. The park aims to create an integrated biomedical industrial park that combines research and development, incubation, production, and multi-functional support, integrating urban functions with industrial elements.</div><div style="padding-bottom: 100px;"> </div>

Shenzhen Pingshan Biomedical Industry Accelerator Park

<div class="container">The Incinta Fertility Center, located near the Pacific Ocean in Torrance, California, occupies over 20,000 square feet and exemplifies the highestquality of assisted reproduction technologies (ART).<br /><br />We carefully considered every detail from site selection to completedconstruction, made possible by a team of exceptionally skilled designers and engineers.</div><div style="padding-bottom: 100px;"> </div>

Yunshida Group

<div class="container">Founded in 2017, Zhaoke Ophthalmology (SEHK: 6622) is a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs in the world. The company was listed in the Main Board of the Hong Kong Stock Exchange on 29 April 2021.
Zhaoke Ophthalmology has a comprehensive drug portfolio of innovative and generic treatments covering six major eye diseases across both the front and back of the eye. Many of the drugs are being produced in its state-of-the-art and fully functional development and production facility in Nansha, Guangzhou.<br><br>Zhaoke Ophthalmology is focusing on advancing towards the goal of product commercialisation,and achieve the objective of improving visual health in China through scientific research as soon as possible.<br><br>Through its ambitious growth strategy, including partnering with domestic and international pharmaceutical companies, Zhaoke Ophthalmology’s goal is to become a leader in ophthalmology in the world.<br /><br />Website: <a style="color: #41aead;" href="https://www.zkoph.com/" target="_blank" rel="noopener">www.zkoph.com</a></div>
</div><div style="padding-bottom: 100px;"> </div>

Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited

<div class="container">ZSHK Laboratories Limited is a biopharmaceutical pre-clinical research and development service company mainly engaged in pre-clinical research and evaluation services for drugs and medical devices. As a one-stop evaluation and research service platform, it provides services including pharmacology, pharmacodynamics, pharmacokinetics, toxicology and other safety-related studies for pharmaceutical developers and researchers worldwide.</div><div style="padding-bottom: 100px;"> </div>

ZSHK Laboratories Limited

Exhibitor

<div class="container">Hong Kong Biotechnology Organization (HKBIO) is an independent nonprofit dedicated to advancing biotechnology and life sciences. Committed to promoting best practices and raising industry awareness, HKBIO supports a diverse community, including students, researchers, entrepreneurs, and public and private sector representatives. Founded by pioneering scientists with deep expertise in life sciences, research, development, engineering, and business, HKBIO works to build a global platform for Hong Kong's biotech sector, foster international collaboration, and offer technical advice to government bodies, healthcare institutions, and the general public. HKBIO is a catalyst for innovation and
scientific excellence.</div><div style="padding-bottom: 100px;"> </div>

Hong Kong Biotechnology Organisation

<div class="container">The Hong Kong College of Health Service Executives (HKCHSE) was established in 2005, in recognition of the emergence of health service management as a specialty in its own right and to promote the professional advancement of health service management. Its predecessor was the Hong Kong Society of Health Service Executives, which was dissolved soon after the establishment of the College.<br /><br />The College has been providing a one-year Dual Fellowship Program in conjunction with the Australasian College of Health Service Management for the past twenty years. The Program targets those healthcare professionals and administrators who have the aspirations in pursuing a career in healthcare administration and management. More than two hundred candidates have successfully completed the program and become fellows of the two Colleges, with several of them taking up senior leadership positions in the healthcare sector of Hong Kong and Macau.</div><div style="padding-bottom: 100px;"> </div>

Hong Kong College of Health Service Executives

<div class="container">The Hong Kong Council of Social Service (HKCSS), a statutory body established since 1947, is committed to building an impact-oriented, collaborative social service sector, and co-creating a better society with its over 520 Agency Members, who provides high-quality social services across Hong Kong. Its Innovation and Technology for Ageing department (ITA) strives to contribute towards a better and more respectable life by gerontechnology. It aims to enhance the development of gerontechnology in Hong Kong by encouraging more application, engaging sectoral dialogues and collaboration in driving related policy development, as well as increasing public awareness and participation.</div><br /><br /><div style="padding-bottom: 100px;"> </div>

Hong Kong Council of Social Service

<div class="container">HK Bio-Med Innotech Association is dedicated to establishing an innovative and international biomedical technology hub in Hong Kong. We actively introduce outstanding biomedical innovation technology projects and industries from overseas and provide comprehensive assistance, including formulating industrialization and commercial development plans, fundraising and listing, corporate governance and auditing, R&D technology, patent protection, policy regulations, clinical trial design and planning, to enter the domestic and Asian markets. Through various projects (exchange activities, talent training, policy recommendations, industry docking, etc.), we promote communication, exchange, and cooperation among the biomedical innovation technology industry, research institutions, investment industry, and government organizations in innovative research and development, industrialization, regulatory policy coordination, investment, and financing.</div><div style="padding-bottom: 100px;"> </div>

HK Bio-Med Innotech Association

<div class="container">HKPC is a multi-disciplinary organisation established by statute in 1967, to promote productivity excellence through relentless drive of world-class advanced technologies and innovative service offerings to support Hong Kong enterprises. Being a key enabler of Industry 4.0 and Enterprise 4.0, HKPC strives to facilitate new industrialisation in Hong Kong, as well as bolstering Hong Kong to be an international innovation and technology hub and a smart city. HKPC’s Green Living and Innovation Division has established the “HealthTech and Chinese Medicine Team”, actively supporting the related development of technological innovation in healthcare.
<br />
  <br />
  Website: <a style="color: #41aead;" href="https://www.hkpc.org/en" target="_blank" rel="noopener">https://www.hkpc.org/en</a></div>

<div style="padding-bottom: 100px;"> </div>

Hong Kong Productivity Council

<div class="container">Incorporated in 1907 with limited liability, The Law Society of Hong Kong (“the Law Society”) is the professional association for solicitors in Hong Kong.<br /><br />As a statutory independent self-regulatory professional body, the Law Society ensures compliance by solicitors with relevant laws and regulations, promotes good standards of practice and provides services to its members. The Law Society also has a certificating role in the solicitors’ admission procedure. It is empowered by law to issue annual practising certificates to Hong Kong solicitors and registration certificates to foreign lawyers and foreign law firms in Hong Kong.<br /><br />As an international legal service centre, Hong Kong is well supported by a strong legal profession equipped with top quality professional expertise in a wide range of legal services to meet the diversified needs of clients.<br /><br />As of the end of February 2025, the Law Society had 13,239 members, out of whom 11,481 had a current practising certificate to practise as a Hong Kong solicitor. There were also 1,578 foreign lawyers qualified primarily from 31 jurisdictions.<br /><br /><strong>Contact Information</strong><br /><br />Address: 3/F Wing On House, 71 Des Voeux Road Central, Hong Kong<br /><br />Tel: 852 2846 0500<br /><br />Fax: 852 2845 0387<br /><br />E-mail: <a href="mailto:adceag@hklawsoc.org.hk">adceag@hklawsoc.org.hk</a><br /><br />Website: <a style="color: #41aead;" href="https://www.hklawsoc.org.hk" target="_blank" rel="noopener">www.hklawsoc.org.hk</a></div><br /><br /><div style="padding-bottom: 100px;"> </div>

Law Society of Hong Kong

<div class="container">Founded in 1968, the Hong Kong Association of the Pharmaceutical Industry (HKAPI) represents 36 Research and Development pharmaceutical company members, including the world’s top 20. Our member companies provide over 70% of the prescription medicines in HK.<br /><br />HKAPI embraces its mission to ensure expeditious access to innovative healthcare solutions for people in HK and Macao with high ethical standards.<br /><br />HKAPI is a platform for the industry working with the government, academics, patients groups and communities, aiming to improve the overall well-being of HK people by making recommendations on improving the accessibility and affordability of medicines for patients in need as well as healthcare policies and regulations.</div><br /><br /><div style="padding-bottom: 100px;"> </div>

The Hong Kong Association of the Pharmaceutical Industry 

<div class="container">Founded in 2003, the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA) is a professional organization dedicated to representing the MedTech industry in Hong Kong.<br /><br />We serve as a platform for the MedTech ecosystem. We facilitate connections among policy makers, industry stakeholders, academia, research and development entities.<br /><br />Our membership comprises innovators, manufacturers, importers, exporters, logistics providers, regulatory bodies, legal professionals, and others involved in the field.<br /><br />As a nonprofit organization, HKMHDIA is committed to promoting the well-being of Hong Kong and is recognized as a caring company.</div><br /><br /><div style="padding-bottom: 100px;"> </div>